Salama, S., Gadallah, A., Fekry, M. (2024). The Role of Serum Lactate as a Prognostic Biomarker in Major Burn Patients: A Prospective Study. The Egyptian Journal of Plastic and Reconstructive Surgery, 48(2), 139-144. doi: 10.21608/ejprs.2024.352136
Sherein Metwally Salama; Ahmed Gadallah; Mohamed Fathi Fekry. "The Role of Serum Lactate as a Prognostic Biomarker in Major Burn Patients: A Prospective Study". The Egyptian Journal of Plastic and Reconstructive Surgery, 48, 2, 2024, 139-144. doi: 10.21608/ejprs.2024.352136
Salama, S., Gadallah, A., Fekry, M. (2024). 'The Role of Serum Lactate as a Prognostic Biomarker in Major Burn Patients: A Prospective Study', The Egyptian Journal of Plastic and Reconstructive Surgery, 48(2), pp. 139-144. doi: 10.21608/ejprs.2024.352136
Salama, S., Gadallah, A., Fekry, M. The Role of Serum Lactate as a Prognostic Biomarker in Major Burn Patients: A Prospective Study. The Egyptian Journal of Plastic and Reconstructive Surgery, 2024; 48(2): 139-144. doi: 10.21608/ejprs.2024.352136
The Role of Serum Lactate as a Prognostic Biomarker in Major Burn Patients: A Prospective Study
The Department of Plastic, Burn and Maxillofacial Surgery, Faculty of Medicine, Ain Shams University
Abstract
Background: Severe burn results in a devastating and unique derangement called burn shock. Fluid resuscitation is the foundation of immediate burn care, and the primary goal of resuscitation is to restore and preserve tissue perfusion. Historically, resuscitation has been guided by a combination of basic laboratory values, invasive maneuvers, and clinical data, but the optimal guide to the end point of resuscitation remains controversial. Objective: The aim of this study is: To investigate the diagnostic and prognostic validity of serum lactate in major burn patients and to determine the utility of an initial and serial serum lactate measurement during the first 36 hours for identifying substantial risk of death and adequacy of fluid resuscitation. Patients and Methods: 40 individuals who had significant burns (greater than 20% of TBSA). Both operated and non-operated patients are included. Twenty were female and twenty were male of the forty cases. The research covered all adult burn patients hospitalized during the first twenty-four hours following their injury. Individuals who were released or died 48 hours after admission, or who were hospitalized after 24 hours following a thermal injury, were not included. Results: As a prognostic tool, serial blood lactate measurements performed better than solitary measurements. 24 hours after admission, lactate levels that were reduced or returned to normal were linked to a better chance of survival. Since serial blood lactate measurements predict death in patients with significant burns, this study validates the predictive utility of serum lactate for mortality in these patients. Conclusion: Our study demonstrated that lactate level in major burn patients is a promising prognostic biomarker, that could facilitate ideal management and initiate proper antimicrobial therapy and good prognostic value as an early predictor of mortality.
WHO (2019): Violence and Injury Prevention [Internet]. [cited 2019 Apr. 20]. 2- Greenhalgh D.G.: Early management of burn patients and fluid resuscitation. In Handbook of Burns. Springer, Cham., 199-209; 1, 2020. 3- Jeschke M.G. and Gauglitz G.G.: Pathophysiology of Burn Injuries. In Handbook of Burns Volume 1. Springer, Cham. , pp. 229-245, 2020. 4- Haberal M., Abali A.E.S. and Karakayali H.: Fluid management in major burn injuries. Indian journal of plastic surgery, 43 (S 01): S29-S36, 2010. 5- D’souza N.T., Kujur A.R. and Rajeswari D.: Understanding the role of serum lactate as an end point in burn resuscitation. Indian Journal of Burns, 28 (1): 7, 2020. 6- Kearns R.D., Conlon K.M., Matherly A.F., Chung K.K., Bebarta V.S., Hansen J.J. and Palmieri T.L.: Guidelines for burn care under austere conditions: Introduction to burn disaster, airway and ventilator management, and fluid resuscitation. Journal of Burn Care & Research, 37 (5): e427-e439, 2016. 7- Pham T.N., Cancio L.C. and Gibran N.S.: American Burn Association practice guidelines burn shock resuscitation. Journal of Burn Care & Research, 29 (1): 257-266, 2008. 8- Nakajima M., Kojiro M., Aso S., Matsui H., Fushimi K., Kaita Y. and Yasunaga H.: Effect of high-dose vitamin C therapy on severe burn patients: A nationwide cohort study. Critical Care, 23 (1): 1-8, 2019. 9- Andersen L.W., Mackenhauer J., Roberts J.C., Berg K.M., Cocchi M.N. and Donnino M.W.: Etiology and therapeutic approach to elevated lactate levels. In Mayo Clinic Proceedings. Elsevier, 88 (10): 1127-1140, 2013. 10- Hayek S., Ibrahim A., Sittah G.A. and Atiyeh B.: Burn resuscitation: Is it straightforward or a challenge? Annals of burns and fire disasters, 24 (1): 17, 2011. 11- Mokline A., Abdenneji A., Rahmani I., Gharsallah L., Tlaili S., Harzallah I. and Messadi A.A.: Lactate: Prognostic biomarker in severely burned patients. Annals of burns and fire disasters, 30 (1): 35, 2017. 12- Vincent J.L., Angus D.C., Artigas A., Kalil A., Basson B.R., Jamal H.H. and Bernard G.R.: Effects of drotrecogin alfa (activated) on organ dysfunction in the PROWESS trial. Critical Care Medicine, 31 (3): 834-840, 2003. Vol. 48, No. 2 / The Role of Serum Lactate as a Prognostic Biomarker i 144 n Major Burn Patients 13- Smith I., Kumar P., Molloy S., Rhodes A., Newman P.J., Grounds R.M. and Bennett E.D.: Base excess and lactate as prognostic indicators for patients admitted to intensive care. Intensive Care Medicine, 27 (1): 74-83, 2001. 14- Husain F.A., Martin M.J., Mullenix P.S., Steele S.R. and Elliott D.C.: Serum lactate and base deficit as predictors of mortality and morbidity. The American Journal of Surgery, 185 (5): 485-491, 2003. 15- Cochran A., Edelman L.S., Saffle J.R. and Morris S.E.: The relationship of serum lactate and base deficit in burn patients to mortality. Journal of Burn Care & Research, 28 (2): 231-240, 2007. 16- Mikkelsen M.E., Miltiades A.N., Gaieski D.F., Goyal M., Fuchs B.D., Shah C.V. and Christie J.D.: Serum lactate is associated with mortality in severe sepsis independent of organ failure and shock. Critical Care Medicine, 37 (5): 1670-1677, 2009. 17- Khosravani H., Shahpori R., Stelfox H.T., Kirkpatrick A.W. and Laupland K.B.: Occurrence and adverse effect on outcome of hyperlactatemia in the critically ill. Critical Care, 13 (3): 1-5, 2009. 18- Nichol A.D., Egi M., Pettila V., Bellomo R., French C., Hart G. and Cooper D.J.: Relative hyperlactatemia and hospital mortality in critically ill patients: A retrospective multi-center study. Critical Care, 14 (1): 1-9, 2010
View on SCiNiTO
Top